148 related articles for article (PubMed ID: 28033598)
1. [Metaphylaxis of urolithiasis - a neglected field in medicine?].
Kościelska M; Mieczkowski M
Wiad Lek; 2016; 69(5):736-741. PubMed ID: 28033598
[TBL] [Abstract][Full Text] [Related]
2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
3. Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium.
Abou Chakra M; Dellis AE; Papatsoris AG; Moussa M
Expert Opin Pharmacother; 2020 Jan; 21(1):85-96. PubMed ID: 31714803
[No Abstract] [Full Text] [Related]
4. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
Murayama T; Taguchi H
Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
[TBL] [Abstract][Full Text] [Related]
6. Prevention of stone disease.
Porena M; Guiggi P; Micheli C
Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
[TBL] [Abstract][Full Text] [Related]
7. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.
Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Leavitt DA; Moeding A; Stessman M; Monga M
Urology; 2012 Feb; 79(2):282-6. PubMed ID: 22000931
[TBL] [Abstract][Full Text] [Related]
9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
10. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
Siener R; Ebert D; Nicolay C; Hesse A
Kidney Int; 2003 Mar; 63(3):1037-43. PubMed ID: 12631085
[TBL] [Abstract][Full Text] [Related]
11. [Studies of urinary risk factors in urolithiasis].
Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
[TBL] [Abstract][Full Text] [Related]
12. [Studies on urolithiasis. The histochemistry of the kidney tissues and stones from patients with urolithiasis].
Tsai S
Hinyokika Kiyo; 1986 Jan; 32(1):27-42. PubMed ID: 2938457
[TBL] [Abstract][Full Text] [Related]
13. A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys.
Bodakhe KS; Namdeo KP; Patra KC; Machwal L; Pareta SK
Chin J Nat Med; 2013 Sep; 11(5):466-71. PubMed ID: 24359768
[TBL] [Abstract][Full Text] [Related]
14. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
Hamid R; Robertson WG; Woodhouse CR
BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
[TBL] [Abstract][Full Text] [Related]
15. Metaphylaxis of urolithiasis.
Menditto VG; Milanese G; Muzzonigro G
Arch Ital Urol Androl; 2009 Mar; 81(1):32-9. PubMed ID: 19499756
[TBL] [Abstract][Full Text] [Related]
16. Diet and stone formation: a brief review of the literature.
Kotsiris D; Adamou K; Kallidonis P
Curr Opin Urol; 2018 Sep; 28(5):408-413. PubMed ID: 29894322
[TBL] [Abstract][Full Text] [Related]
17. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.
Singh P; Enders FT; Vaughan LE; Bergstralh EJ; Knoedler JJ; Krambeck AE; Lieske JC; Rule AD
Mayo Clin Proc; 2015 Oct; 90(10):1356-65. PubMed ID: 26349951
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
Murayama T; Taguchi H
Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
[TBL] [Abstract][Full Text] [Related]
19. Nutritional Management of Urolithiasis.
Queau Y
Vet Clin North Am Small Anim Pract; 2019 Mar; 49(2):175-186. PubMed ID: 30583809
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities of using dietary supplements with antioxidant properties in urinary stone disease].
Prosiannikov MY; Konstantinova OV; Golovanov SA; Anokhin NV; Voitko DA
Urologiia; 2020 Sep; (4):55-59. PubMed ID: 32897015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
